Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2002
03/21/2002WO2002022595A1 N-substituted benzothiophenesulfonamide derivatives
03/21/2002WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors
03/21/2002WO2002022572A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
03/21/2002WO2002022562A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
03/21/2002WO2002022559A2 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
03/21/2002WO2002006255A3 Hydroxy-(piperidin-4-yl-methylamino)-alkyl beta-3 adrenergic receptor antagonists
03/21/2002WO2001014372A3 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
03/21/2002US20020035113 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
03/21/2002US20020035094 Substituted pyridine compounds and methods of use
03/21/2002US20020035064 Method for treating atherosclerosis employing an aP2 inhibitor and combination
03/21/2002CA2422376A1 Isoxazoles and their use as inhibitors of erk
03/21/2002CA2422055A1 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
03/21/2002CA2420007A1 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
03/21/2002CA2419224A1 Chemokine receptor binding heterocyclic compounds
03/21/2002CA2419219A1 Chemokine receptor binding heterocyclic compounds
03/21/2002CA2418720A1 Caspase inhibitors and uses thereof
03/20/2002EP1188747A1 Phenoxypropylamine compounds
03/20/2002EP1187856A1 Transition metal complexes and olefin polymerization process
03/20/2002EP1187832A1 Amino heterocycles useful as pharmaceutical agents
03/20/2002EP1187827A1 Antiviral agents
03/20/2002EP1187821A1 Benzofuranylsulfonates
03/20/2002EP1187819A1 N-substituted perhydro diazine
03/20/2002EP1187614A1 Substituted piperidines as melanocortin-4 receptor agonists
03/20/2002EP1019050B1 Use of somatostatin agonists and antagonists for treating diseases related to the eye
03/20/2002EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/20/2002CN1341104A 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
03/19/2002US6359142 Fungicides; bactericides
03/19/2002US6358983 Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists
03/19/2002US6358979 N-cyclopentyl modulators of chemokine receptor activity
03/19/2002US6358978 Substituted benzimidazoles
03/19/2002US6358976 For therapy and prophylaxis of cancer metastasis, diabetic retinopathy, neovascular glaucoma, thrombosis, restenosis, osteoporosis, or macular degeneration
03/19/2002US6358972 5-HT1F agonists
03/19/2002US6358960 For therapy of intravascular coagulation, coronary thrombosis, cerebral infarction, cerebral embolism, transient ischemic attack, cerebrovascular disorders, pulmonary vascular diseases, deep venous thrombosis, etc.
03/19/2002US6358948 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
03/19/2002US6358945 Compounds useful as anti-inflammatory agents
03/19/2002US6358942 Microbiocides and bactericides for treating grampositive, bacteroides, clostridium, mycobacterium, staphylococcus and streptococcus infections
03/19/2002US6358634 Nitrogen-containing heterocyclic compound, organic light-emitting device material and organic light-emitting device
03/19/2002US6358286 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected
03/14/2002WO2002020670A1 Oxazine derivatives
03/14/2002WO2002020515A1 Oxazolidinone antibacterial agents
03/14/2002WO2002020512A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
03/14/2002WO2002020495A2 Inhibitors of glycogen synthase kinase 3
03/14/2002WO2002020485A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/14/2002WO2002020484A1 Chemical compounds
03/14/2002WO2002020474A2 Resorcinol derivatives
03/14/2002WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
03/14/2002WO2002020437A2 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them
03/14/2002WO2002020436A2 Methods for forming combinatorial libraries combining amide bond formation with epoxide opening
03/14/2002WO2002020011A2 A method for treating allergies using substituted pyrazoles
03/14/2002WO2002020008A1 Inhibitors of nadh:ubiquinone oxidoreductase
03/14/2002WO2002019825A1 Herbicidal 5-benzyloxymethyl-1,2-isoxazoline derivatives
03/14/2002WO2001070734A3 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
03/14/2002WO2001070692A3 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides
03/14/2002WO2001070673A3 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a)
03/14/2002WO2001068612A3 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
03/14/2002WO2001055134A3 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vassopressin receptors
03/14/2002WO2001047918A3 Azolyalkyl-oxa(di)azolyl pyri(mi)dine derivatives, a method for their production and their use as pesticides
03/14/2002US20020032348 Bactericides; reacting imine, carbamate, ester, amide and epoxide derivatives
03/14/2002US20020032328 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides
03/14/2002US20020032224 Treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system disorders
03/14/2002US20020032208 Chemical compounds
03/14/2002US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
03/14/2002US20020032191 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors
03/14/2002DE10065434A1 Indole Indoles
03/14/2002CA2421493A1 A method for treating allergies using substituted pyrazoles
03/14/2002CA2421172A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
03/14/2002CA2417177A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/13/2002EP1186603A2 Processes for preparing endothelin antagonists
03/13/2002EP1186318A2 Combination, for treating depression and anxiety, containing a 5HT1d receptor antagonist and aCNS penetrant NK-1 receptor antagonist
03/13/2002EP1185524A2 3-heteroarylalkyl substituted gaba analogs
03/13/2002EP1185512A2 INHIBITORS OF FACTOR Xa
03/13/2002EP1185511A2 Inhibitors of factor xa
03/13/2002EP1185275A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
03/13/2002EP0975219B1 Fungicide active substance combinations
03/13/2002EP0770067B1 Substituted cinnamic oxime and hydroxamide derivatives
03/13/2002CN1340053A Epothilon derivatives, method for the production and the use as pharmaceuticals
03/13/2002CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists
03/13/2002CN1080719C Substituted 1H-3-aryl-pyrrolidine-2,4-diones derivatives
03/12/2002US6355810 Multibinding inhibitors of HMG-CoA reductase
03/12/2002US6355807 Multistep process including cyanomethylation, reduction, cyclization, deprotection, oxidation, olefination and amidation
03/12/2002US6355805 β3-adrenergic receptor agonists
03/12/2002US6355796 Reacting beta-amino-beta-(perfluoroalkyl)acrylate compound with base and carbamoyl chloride compound to form urea compound, reacting urea compound with phosphorus pentahalide or oxalyl halide
03/12/2002US6355663 An enhancing agent for the action of cell differentiation induction factors for bone disorders and nervous system disorders
03/12/2002US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents
03/12/2002US6355641 Oxazolone derivatives and uses thereof
03/12/2002US6355637 Local anesthetic compounds
03/12/2002US6355615 Cyclic polyamideester copolymers
03/07/2002WO2002018377A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists
03/07/2002WO2002018373A1 Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
03/07/2002WO2002018368A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
03/07/2002WO2002018355A1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
03/07/2002WO2002018354A1 Oxazolidinones and their use as antibacterial agents
03/07/2002WO2002018353A2 Oxazolidinone chemotherapeutic agents
03/07/2002WO2002018346A1 Pyrazole derivatives and their use as protein kinase inhibitors
03/07/2002WO2002017924A1 Method of treatment
03/07/2002WO2001077100A3 Benzoamide piperidine compounds as substance p antagonists
03/07/2002WO2001062765A3 Small molecule modulators of g protein-coupled receptor six
03/07/2002US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis
03/07/2002US20020028835 Cyclic amine phenyl beta-3 adrenergic receptor agonists
03/07/2002US20020028834 Heterocyclic-cyclic amine derivatives